View of Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study

Return to Article Details Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study Download Download PDF